{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:20:32Z","timestamp":1791429632349,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ijpharm.2016.12.026","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T21:01:49Z","timestamp":1481576509000},"page":"312-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor"],"prefix":"10.1016","volume":"517","author":[{"given":"Shaimaa","family":"Makled","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Nafee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Boraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.12.026_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.colsurfb.2012.02.024","article-title":"Elaboration and characterization of nanoliposome made of soya; rapeseed and salmon lecithins: application to cell culture","volume":"95","author":"Arab Tehrany","year":"2012","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.colsurfb.2015.07.020","article-title":"Solid lipid nanoparticles for delivery of Calendula officinalis extract","volume":"135","author":"Arana","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejpb.2006.12.004","article-title":"Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization","volume":"67","author":"Attama","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/vhrm.2006.2.4.411","article-title":"Sildenafil in the treatment of pulmonary hypertension","volume":"2","author":"Barnett","year":"2006","journal-title":"Vasc. Health Risk Manage."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijpharm.2011.10.012","article-title":"Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb\u00ae Pro: formulation aspects and nanoparticle stability to nebulization","volume":"422","author":"Beck-Broichsitter","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jconrel.2011.09.058","article-title":"Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters","volume":"157","author":"Beck-Broichsitter","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2007.09.006","article-title":"Pathogenic mechanisms of pulmonary arterial hypertension","volume":"44","author":"Chan","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2008.04.001","article-title":"Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique: II. In vitro drug release studies and release mechanisms","volume":"359","author":"Cheboyina","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-1634-1","article-title":"Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles","volume":"15","author":"Chuan","year":"2013","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2011.07.009","article-title":"Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA","volume":"419","author":"Dong","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.colsurfb.2015.08.027","article-title":"Overcoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptide","volume":"135","author":"d\u2019Angelo","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijpharm.2012.06.064","article-title":"Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients","volume":"436","author":"Elhissi","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2011.12.037","article-title":"Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size","volume":"424","author":"Ghadiri","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2008-2231-21-68","article-title":"Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design","volume":"21","author":"Ghasemian","year":"2013","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0075","doi-asserted-by":"crossref","first-page":"D82","DOI":"10.1016\/j.jacc.2013.10.026","article-title":"New trial designs and potential therapies for pulmonary artery hypertension","volume":"62","author":"Gomberg-Maitland","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.colsurfb.2014.05.041","article-title":"Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment","volume":"121","author":"Jain","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.colsurfb.2015.06.027","article-title":"Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin","volume":"134","author":"Jain","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-5173(99)00426-3","article-title":"Comparison of wax and glyceride solid lipid nanoparticles (SLN\u00ae)","volume":"196","author":"Jenning","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2009.10.022","article-title":"Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles","volume":"390","author":"Jensen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.colsurfb.2015.02.046","article-title":"Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles","volume":"128","author":"Kelidari","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"September (3)","key":"10.1016\/j.ijpharm.2016.12.026_bib0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jvc.2015.04.002","article-title":"Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005\u20132014","volume":"17","author":"Kellihan","year":"2015","journal-title":"J. Vet. Cardiol."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.colsurfb.2012.08.052","article-title":"Preparation and characterization of Paliperidone loaded solid lipid nanoparticles","volume":"102","author":"Kumar","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.colsurfa.2012.10.031","article-title":"Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: physicochemical investigations","volume":"416","author":"Kumbhar","year":"2013","journal-title":"Coll. Surf. A: Physicochem. Eng. Aspects"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0120","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1345\/aph.1E426","article-title":"Sildenafil for pulmonary hypertension","volume":"39","author":"Lee","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10973-009-0127-z","article-title":"Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method","volume":"99","author":"Li","year":"2010","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0140","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/jps.10469","article-title":"Physicochemical properties of sildenafil citrate (viagra) and sildenafil base","volume":"92","author":"Melnikov","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejpb.2011.11.019","article-title":"Treatment of lung cancer via telomerase inhibition: self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2'-O-methyl-RNA","volume":"80","author":"Nafee","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2014.06.055","article-title":"Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors","volume":"192","author":"Nafee","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2010.02.014","article-title":"A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung","volume":"75","author":"Nassimi","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.forsciint.2013.01.043","article-title":"Counterfeit Cialis and Viagra fingerprinting by ATR-FTIR spectroscopy with chemometry: can the same pharmaceutical powder mixture be used to falsify two medicines?","volume":"226","author":"Ortiz","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/08958378.2013.810315","article-title":"In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles","volume":"25","author":"Paranjpe","year":"2013","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2014.09.031","article-title":"Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application","volume":"476","author":"Paranjpe","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2011.07.040","article-title":"Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application","volume":"419","author":"Pardeike","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2005.10.005","article-title":"Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertension","volume":"96","author":"Patel","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0185","first-page":"1753","article-title":"Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment","volume":"8","author":"Pitsiou","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2008.10.016","article-title":"Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy","volume":"369","author":"Plumley","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0195","first-page":"1621","article-title":"Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent","volume":"21","author":"Ranjha","year":"2010","journal-title":"J. Mater. Sci.: Mater. Med."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.colsurfb.2015.04.055","article-title":"Modification of oral absorption of oxyresveratrol using lipid based nanoparticles","volume":"131","author":"Sangsen","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejps.2005.10.004","article-title":"Structural investigations on lipid nanoparticles containing high amounts of lecithin","volume":"27","author":"Schubert","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.colsurfb.2015.03.049","article-title":"Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: antibiotic resistance tests and HaCat and NIH\/3T3 cell viability studies","volume":"129","author":"Severino","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5138\/ijdd.2010.0975.0215.02031","article-title":"Formulation of sildenafil citrate loaded nasal microsphers: an in vitro, ex vivo characterization","volume":"2","author":"Shah","year":"2010","journal-title":"Int. J. Drug Delivery"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0220","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/ajrccm.165.8.2107097","article-title":"Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension","volume":"165","author":"Shekerdemian","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0225","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.scitotenv.2012.06.018","article-title":"In vitro biocompatibility of solid lipid nanoparticles","volume":"432","author":"Silva","year":"2012","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2011.02.012","article-title":"Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release","volume":"79","author":"Souza","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2011.08.010","article-title":"Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers","volume":"157","author":"Ungaro","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2015.05.287","article-title":"Novel therapeutic approaches for pulmonary arterial hypertension: unique molecular targets to site-specific drug delivery","volume":"211","author":"Vaidya","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2013\/136859","article-title":"Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery","volume":"2013","author":"Varshosaz","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0250","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","article-title":"Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles","volume":"95","author":"Venkateswarlu","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.colsurfb.2010.12.024","article-title":"The size of solid lipid nanoparticles: an interpretation from experimental design","volume":"84","author":"Vitorino","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1208\/pt0804083","article-title":"Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles","volume":"8","author":"Vivek","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0265","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/00000542-200006000-00030","article-title":"Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension","volume":"92","author":"Weimann","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijpharm.2016.12.026_bib0270","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.colsurfb.2007.06.011","article-title":"Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification","volume":"60","author":"Yuan","year":"2007","journal-title":"Colloids Surf. B: Biointerfaces"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316311681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316311681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T02:20:10Z","timestamp":1536200410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316311681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":54,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0378517316311681"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.12.026","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}